Immunotherapy improves lung cancer survival by harnessing the body’s immune system to recognize and attack cancer cells. Drugs like immune checkpoint inhibitors block signals that cancer cells use to evade the immune response, allowing the immune system to target and destroy them. This approach has shown remarkable success, leading to longer survival and even durable responses in some patients. Immunotherapy offers a promising avenue for enhancing treatment outcomes in lung cancer and has transformed the landscape of cancer therapy.
Sunscreen can give a false sense of security by providing a physical barrier to the sun’s harmful UV rays, which can make people believe they are fully protected. This may lead individuals to spend more time in the sun than they should, engage in riskier behaviors like not seeking shade or wearing protective clothing, and […]
Professor Li Tang’s groundbreaking research enhances CAR-T cell therapy by introducing a new dimension to target solid tumors. Co-founding Leman Biotech with Yugang Guo, Tang’s bioengineered CAR-T cells excrete the IL-10 molecule, traditionally seen as an immune suppressant. Rather than inhibiting the immune response, this innovation reinforces metabolic capabilities, addressing the challenge of CAR-T cells […]
Treatments for metastatic breast cancer have played a pivotal role in reducing mortality rates. Advances in targeted therapies, hormone therapies, and immunotherapies have improved the effectiveness of treatments, slowing disease progression and enhancing overall survival. Early detection, personalized treatment plans, and a multidisciplinary approach have also contributed. Patients now benefit from a more comprehensive understanding […]